ES8706122A1 - Un procedimiento para la preparacion de agentes inotropicos de quinolona - Google Patents

Un procedimiento para la preparacion de agentes inotropicos de quinolona

Info

Publication number
ES8706122A1
ES8706122A1 ES551343A ES551343A ES8706122A1 ES 8706122 A1 ES8706122 A1 ES 8706122A1 ES 551343 A ES551343 A ES 551343A ES 551343 A ES551343 A ES 551343A ES 8706122 A1 ES8706122 A1 ES 8706122A1
Authority
ES
Spain
Prior art keywords
alkyl
inotropic agents
quinolone
formula
quinolone inotropic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551343A
Other languages
English (en)
Other versions
ES551343A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp SRL filed Critical Pfizer Corp SRL
Publication of ES551343A0 publication Critical patent/ES551343A0/es
Publication of ES8706122A1 publication Critical patent/ES8706122A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)

Abstract

METODO PARA PREPARAR AGENTES INOTROPICOS DE QUINOLONA. CONSISTE EN DESMETILAR UN COMPUESTO DE FORMULA (II) CON UNA SOLUCION ACUOSA DE ACIDO MINERAL O EN ETANOL, PARA OBTENER AGENTES INOTROPICOS DE QUINOLONA Y SUS SALES FARMACEUTICAMENTE ACEPTABLES DE FORMULA (I) DONDE N ES 0, 1 O 2; R1 ES -NR4R5, -NR4CO ALQUILO DE C 1 A 4, -OCO ALQUILO DE C 1 A 4, -S(O)M ALQUILO DE C 1 A 4, HIDROXI, CIANO, HALOGENO Y OTRIS; R3 ES H O ALQUILO DE C 1 A 4; X ES H, ALQUILO DE C 1 A 4, ALCOXI DE C 1 A 4 Y OTROS; Y LA LINEA DE PUNTOS ENTRE LAS POSICIONES 3 Y 4 REPRESENTA UN ENLACE OPCIONAL. TIENEN APLICACIONES FARMACEUTICAS COMO ESTIMULANTES CARDIACOS.
ES551343A 1985-01-30 1986-01-28 Un procedimiento para la preparacion de agentes inotropicos de quinolona Expired ES8706122A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502267A GB8502267D0 (en) 1985-01-30 1985-01-30 Quinolone inotropic agents
CN85104392A CN85104392B (zh) 1985-01-30 1985-06-10 喹诺酮变力剂的制备方法

Publications (2)

Publication Number Publication Date
ES551343A0 ES551343A0 (es) 1987-06-01
ES8706122A1 true ES8706122A1 (es) 1987-06-01

Family

ID=25741743

Family Applications (2)

Application Number Title Priority Date Filing Date
ES551343A Expired ES8706122A1 (es) 1985-01-30 1986-01-28 Un procedimiento para la preparacion de agentes inotropicos de quinolona
ES557430A Expired ES8801902A1 (es) 1985-01-30 1987-02-27 Un procedimiento para la preparacion de agentes inotropicos de quinolona

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557430A Expired ES8801902A1 (es) 1985-01-30 1987-02-27 Un procedimiento para la preparacion de agentes inotropicos de quinolona

Country Status (18)

Country Link
US (1) US4728654A (es)
EP (1) EP0190857B1 (es)
JP (1) JPS61176568A (es)
KR (1) KR880000132B1 (es)
CN (1) CN85104392B (es)
AT (1) ATE51224T1 (es)
AU (1) AU557667B2 (es)
CA (1) CA1255662A (es)
DE (1) DE3669714D1 (es)
DK (1) DK43286A (es)
ES (2) ES8706122A1 (es)
FI (1) FI860424A7 (es)
GB (1) GB8502267D0 (es)
GR (1) GR860249B (es)
HU (1) HU194831B (es)
IE (1) IE860258L (es)
PL (1) PL257669A1 (es)
PT (1) PT81921B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582909A (en) * 1984-02-02 1986-04-15 Warner-Lambert Company Benzobicyclic lactam acids and derivatives as cognition activators
US4797490A (en) * 1984-12-06 1989-01-10 Pfizer Inc. Process for the preparation of 3-(2'-fluorophenyl)pyridine
GB8709448D0 (en) * 1987-04-21 1987-05-28 Pfizer Ltd Heterobicyclic quinoline derivatives
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−３，４−ジヒドロカルボスチリル誘導体
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
CN102532015B (zh) * 2012-01-18 2013-10-23 云南大学 香豆素及其类似物的固相合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3287459A (en) * 1961-10-23 1966-11-22 Chattanooga Medicine Co Carbostyrils, coumarines and thiocoumarines
US3668207A (en) * 1970-01-22 1972-06-06 Ciba Geigy Corp 2-amino-4-aryl-quinolines
BE884459Q (fr) * 1971-05-14 1981-01-26 Boehringer Mannheim Gmbh Derives de la 4-(omega-(coumarine-7-yl-oxy)-alkyl)-piperazine et procede de preparation
DE2123923A1 (de) * 1971-05-14 1972-11-23 Boehringer Mannheim Gmbh, 6800 Mannheim 4-eckige Klammer auf omega- (Flavon-7yl-oxy) -alkyl eckige Klammer zu -pigerazin-Derivate und Verfahren zu ihrer Herstellung
JPS4976877A (es) * 1972-11-28 1974-07-24
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones
DE2827566A1 (de) * 1978-06-23 1980-01-10 Boehringer Mannheim Gmbh 1,2-dihydro-chinolin-2-on-derivate und verfahren zu ihrer herstellung
HU190412B (en) * 1981-09-17 1986-09-29 Warner-Lambert Co,Us Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
US4503061A (en) * 1983-07-22 1985-03-05 Warner-Lambert Company Substituted phenyl-pyridinones as cardiotonic agents
IL69407A (en) * 1982-08-23 1987-10-20 Warner Lambert Co 2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
US4550119A (en) * 1983-05-23 1985-10-29 Warner-Lambert Company 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
NZ212209A (en) * 1984-05-29 1988-08-30 Pfizer Quinolone derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
HUT40421A (en) 1986-12-28
GB8502267D0 (en) 1985-02-27
IE860258L (en) 1986-07-30
ATE51224T1 (de) 1990-04-15
ES8801902A1 (es) 1988-03-01
PT81921A (en) 1986-02-01
EP0190857B1 (en) 1990-03-21
PT81921B (en) 1987-11-16
ES557430A0 (es) 1988-03-01
KR860005790A (ko) 1986-08-13
KR880000132B1 (ko) 1988-03-12
PL257669A1 (en) 1987-05-18
EP0190857A3 (en) 1987-08-19
ES551343A0 (es) 1987-06-01
AU5279886A (en) 1986-08-07
JPS61176568A (ja) 1986-08-08
DK43286A (da) 1986-07-31
DK43286D0 (da) 1986-01-29
FI860424A7 (fi) 1986-07-31
DE3669714D1 (de) 1990-04-26
AU557667B2 (en) 1987-01-08
HU194831B (en) 1988-03-28
EP0190857A2 (en) 1986-08-13
CN85104392B (zh) 1988-02-17
FI860424A0 (fi) 1986-01-29
GR860249B (en) 1986-05-29
CA1255662A (en) 1989-06-13
US4728654A (en) 1988-03-01
CN85104392A (zh) 1986-12-24

Similar Documents

Publication Publication Date Title
ES8406455A1 (es) Un procedimiento de preparacion de nuevos acidos 2-4-difenil-metil)piperazinil-aceticos.(como divisional de la patente numero 509.358)
ES8603863A1 (es) Un procedimiento para la preparacion de agentes inotropicos de quinolona.
ES8102559A1 (es) Un procedimiento para la preparacion de la forma racemica y de las formas esteroisomeras de ellas de un derivado del a- cido 1,2,3,4-tetrahidro-2-quinolincarboxilico
SE7703263L (sv) Forfarande for framstellning av nya acetohydroxaminsyror
MX162950B (es) Procedimiento para preparar derivados de acidos piridoncarboxilicos
ES8801222A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES8801241A1 (es) Un procedimiento para preparar laudanos
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
ES8800222A1 (es) Procedimiento para la obtencion del acido 2,6-dicloro-5-fluor-piridin-3-carboxilico
SE7903976L (sv) Nya purinderivat anvendbara sasom icke-adrenenergiska bronkodilatorer
ES8608503A1 (es) Procedimiento para la fabricacion de nuevos derivados de la cumarina
ES8801174A1 (es) Un procedimiento para la preparacion de derivados de tetrahidronaftaleno.
ES2010439A6 (es) Procedimiento para la preparacion de nuevas sales antivirales y estimuladoras del sistema inmunologico.
ES2039272T3 (es) Sales opticamente activas a base de un tiazolidin-4-carboxilato sustituido y 3-cloro-2-hidroxipropiltrimetilamonio, su preparacion y empleo.
ES8707723A1 (es) Un procedimiento para la preparacion de derivados de 1,5-benzotiazepina
IT1188178B (it) Sali della citidin-difospocolina particolarmente idonei per uso orale
ES8802050A1 (es) Procedimiento para la obtencion de acidos 4-quinolon-3-carboxilicos 1,8-puenteados
ES2044908T3 (es) Procedimiento para la produccion de derivados de quinazolina.
IT7926964A0 (it) Procedimento per la produzione di derivati dell'acido fenossicarbossilico.
ES2020925B3 (es) Nuevas sales cristalinas de ariloxipropanolaminas, procedimiento para su preparacion y utilizacion de las mismas.
ES8404363A1 (es) Procedimiento para la preparacion de tiazolo(3,2-a)pirimidinas sustituidas.
ES8104291A1 (es) Un procedimiento para la preparacion de imidazobenzodiacepi-nas
ES8702390A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina
ES468127A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirido (2,1-b) quinazolina
ES8504182A1 (es) Procedimiento para preparar nuevos derivados de piperidina